Showing results (101-110 of 150) with videos related to
Sort By:
Pageof 15
ACS Infectious Diseases|July 26, 2022
Optimization of Potent and Specific Trypanothione Reductase Inhibitors: A Structure-Based Drug Discovery ApproachTheo Battista, Stefano Federico, Simone Brogi, et al.European Journal of Medicinal Chemistry|December 3, 2022
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditionsAlessandro Papa, Silvia Pasquini, Francesca Galvani, et al.European Journal of Medicinal Chemistry|February 18, 2021
Synthesis and biological evaluation of benzhydryl-based antiplasmodial agents possessing Plasmodium falciparum chloroquine resistance transporter (PfCRT) inhibitory activityNicola Relitti, Stefano Federico, Luca Pozzetti, et al.Journal of Medicinal Chemistry|May 21, 2010
Discovery of bishomo(hetero)arylpiperazines as novel multifunctional ligands targeting dopamine D(3) and serotonin 5-HT(1A) and 5-HT(2A) receptorsStefania Butini, Giuseppe Campiani, Silvia Franceschini, et al.European Journal of Medicinal Chemistry|August 31, 2015
Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agentsAndrea Spallarossa, Chiara Caneva, Matteo Caviglia, et al.European Journal of Medicinal Chemistry|November 17, 2020
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigationNicola Relitti, A Prasanth Saraswati, Giulia Chemi, et al.RSC Medicinal Chemistry|February 4, 2026
Oxyprenyl-chalcones as antibacterial hits: design of experiments-optimized synthesis, antibacterial evaluation, early drug-like profiling and biodegradability predictionLudovica Marotta, Francesca Maria Pia Rita Giammarino, Brondon Brandly Senenou Tambou, et al.Apoptosis : an International Journal on Programmed Cell Death|July 4, 2026
Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4Vanessa Tatangelo, Gabriele Carullo, Ludovica Lopresti, et al.Journal of Medicinal Chemistry|January 28, 2009
Specific targeting of highly conserved residues in the HIV-1 reverse transcriptase primer grip region. 2. Stereoselective interaction to overcome the effects of drug resistant mutationsStefania Butini, Margherita Brindisi, Sandro Cosconati, et al.Journal of Medicinal Chemistry|July 12, 2012
Discovery of potent inhibitors of human and mouse fatty acid amide hydrolasesStefania Butini, Margherita Brindisi, Sandra Gemma, et al.Pageof 15